Types of surgery for ovarian, fallopian tube or primary peritoneal cancer
Surgery involves removing all or part of the cancer with an operation. It is an important treatment for many cancers.
Surgery is one of the main treatments for cancer of the ovary, fallopian tube or peritoneum. It is also sometimes used to diagnose the cancer and to find out more about the type and stage of the cancer. A surgeon called a gynaecological oncologist will do your operation.
The type of surgery you have may depend on:
- the stage of the cancer
- the areas affected by cancer
- whether you want to be able to get pregnant in the future.
Before you have surgery, your surgeon and nurse will explain what to expect and answer any questions you have. It may help to look at the diagrams of organs close to the ovaries when reading this section.
The aim of this operation is to remove all of the cancer.
The surgeon usually removes:
- the ovaries and fallopian tubes (called a bilateral salpingo‑oophorectomy or BSO)
- the womb and cervix (called a total abdominal hysterectomy or TAH)
- the omentum (called an omentectomy).
During the operation, the surgeon:
- takes samples (biopsies) from other areas nearby
- may remove some of the lymph nodes in the abdomen and pelvis
- puts fluid into the abdomen and collects it again (called abdominal or peritoneal washing).
After the operation, everything that the surgeon removed is sent to the laboratory and carefully examined. This gives more information about the type and stage of the cancer. This information helps your team decide if you are likely to need further treatment.
If you are still having periods, this surgery will bring on your menopause and you will not be able to get pregnant. Your surgeon or nurse will explain what to expect before you have surgery. Ask them for advice if you are worried about your fertility.
Some women choose to have surgery that protects their fertility (ability to get pregnant). This may be possible if cancer or a borderline tumour is only affecting one ovary or fallopian tube.
In fertility-sparing surgery the surgeon only removes the affected ovary and fallopian tube. They leave the other ovary, fallopian tube and the womb. This means you may still be able to get pregnant in the future.
During the operation, the surgeon checks the other ovary and may take a sample from it. They will also take washings and samples (biopsies) from other nearby areas. They may remove some lymph nodes from the pelvis or abdomen.
If the washings, biopsies or lymph nodes show the cancer has spread, you may need another operation. This usually involves removing the womb, omentum and remaining ovary and fallopian tube.
When cancer has spread to other areas in the pelvis or abdomen, it is not always possible to remove it all. Instead, the surgeon aims to remove as much of the cancer as they can. This is called debulking or cytoreductive surgery. It helps keep the cancer under control and may improve any symptoms you have.
If the cancer has spread to the outside of the bowel, you may also need a section of bowel removed. If possible, the surgeon removes the affected piece of bowel and joins the two remaining pieces together.
Rarely, the surgeon cannot safely join the bowel back together. Instead, they bring the upper end of the bowel out onto the skin of the abdomen. This is called a stoma. After the surgery, you wear a bag over the stoma to collect poo (stools).
If you are likely to need part of your bowel removed, your surgeon will talk to you about this before your surgery. If you need a stoma, your hospital team and a stoma nurse will give you support and advice.
Ovarian cancer references
Below is a sample of the sources used in our ovarian cancer information. If you would like more information about the sources we use, please contact us at firstname.lastname@example.org
Fotopoulou C, et al. British Gynaecological Cancer Society (BGCS) epithelial ovarian/ fallopian tube/ primary peritoneal cancer guidelines: recommendations for practice. European Journal of Obstetrics, gynecology, and reproductive biology. 2017. 213: 123-139.
National Institute for Health and Care Excellence. Ovarian cancer: recognition and initial management. Clinical guideline (CG122). April 2011. Available from: www.nice.org.uk/Guidance/CG122 (accessed June 2017).
Germ cell ovarian cancer references
Below is a sample of the sources used in our germ cell ovarian cancer information. If you would like more information about the sources we use, please contact us at email@example.com
Royal College of Obstetricians and Gynaecologists. Management of female malignant ovarian germ cell tumours. Scientific impact paper no.52. Nov 2016. Available from: www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_52.pdf (accessed June 2017)
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editor, Professor David Luesley, Professor of Gynaecological Oncology.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.